Global Institute Of Stem Cell Therapy And Research

Category

News

Asian Heritage SocietyHope Springs Eternal.

When it comes to stem cell therapy, it could be an eternity.

That’s why GIOSTAR of San Diego is pushing the stem cell research community to act more aggressively to overcome politics and red tape. It is delaying and preventing the United States from taking the lead in the therapeutic applications. “If America is not working aggressively, we will lose out to Asia”, contends Deven Patel, president, CEO and co-founder of the Global Institute of Stem Cell Therapy and Research (GIOSTAR) of La Jolla, California.

Countries like China, Thailand and India have expedited the process of clinical trials required by the United States and forge ahead into treating degenerative diseases, for which stem cell research holds much promise. Biotechnology is growing so fast in China, that within the next decade, it is expected to comprise 60 percent of that country’s growth! Thailand, another center of therapeutic applications, is the one of the few places in the world — Bangkok Hospital — where stem cell therapy has been developed commercially to tackle congestive heart failure.

Dr. Anand Srivastava Mr Deven Patel Speech Dr Anand Srivastava And Mr. Deven Patel

“If we are going to take too much time, these countries will take the lead,” Deven Patel added – an irony since it has been the United States, the Salk Research Institute, UCSD, UCI, UCLA, Sanford-Bernham and scientists like GIOSTAR’s Chairman and Co-founder Dr. Anand Srivastava who has been associated with these leading universities and research institutions have pioneered the research for more than dozen years and published extensively in revered scientific journals. Dr. Anand Srivastava has an extensive research experience in the field of adult and Embryonic Stem (ES) cell, which is documented by several publications in revered scientific journals. Dr. Anand Srivastava’s expertise and scientific achievements were recognized by many scientific fellowships and by two consecutive award of highly prestigious and internationally recognized, JISTEC award from Science and Technology Agency, Government of Japan. Based on his extraordinary scientific achievements his biography has been included in “WHO IS WHO IN AMERICA” data bank two times, first in 2005 and second in 2010.

Dr. Srivastava says, “While stem cell therapy is on the verge of revolution in parts of Asia, it is still regarded in some U.S. medical circles as risky and under the process of development, principally because of the association with ES cells, whose use has led to a high incidence of tumors and carcinoma”. But research has advanced so much in recent years, that ES cells research has been complemented with the use of induced pluripotent cells (iPSC), Dr. Srivastava added. iPSCs are derived from reprogramming a mature adult cell to give it back the properties of an embryonic stem cell. In order for this adult cell to return to a state of immaturity and be able to differentiate into all cell types. Dr. Srivastava says “the beauty of this science is that clinicians do not need to match the cells for transplant because iPSCs can be generated from a patient own cells, who is seeking for medical treatment”.

Dr.Anand Srivastava with knowledge of stem cells for public and private entities. Sees the availability of a Medical Miracle in the hub of Asia.

The Availability of a Medical Miracle in the Hub of Asia - Thailand

Stem cell plasticity Thailand leading knowledge of stem cell therapy

Scientists celebrated the stem cell therapy in the United States, “Dr. Anand” with knowledge of stem cells for government agencies and. private Sees the availability of a Medical Miracle in the hub of Asia.

Dr. Anand T. Wa Si Sawat (Dr.Anand Srivastava) President and Founder of Research and Therapy, Stem Cells. As a specialist in stem cells, said their attention to studying stem cells since 1990, especially in the genes. For medicinal purposes Because it is well known that stem cells are. The cells are present in a person’s body. Meanwhile, medical extraction of stem cells from different organs in the body in order to maintain or repair other organs are damaged. These include the treatment of diseases such as blood or Roma Katha thalassemia in medical stem cells. Is a special type of stem cells found in all periods of growth in living organisms. An important role in the proliferation of cells proliferate and differentiate into different types. To replace aging cells in the body can be divided into two major categories. Stem cells isolated from embryos. And stem cells derived from adult organisms or tissues Dr. Anand said in Thailand this time. To convey the knowledge of stem cells to scientists and organizations interested Thailand. Because of the current public attention to the issue of stem cells more.

Anyone can find out about the car of the Google logo. In particular, the stem cells to treat disease, when asked about the treatment with stem cells in that the cost is very high, Dr. Anand said he was not aware of the cost of. treatment of ThailandBut the cost in America. Or in countries where the treatment with stem cells is about. 50,000-60,000 US dollars in private thought. The cost of a stem cell treatment can be reduced. It requires the development of a stem cell therapy accessible in all groups. Which meet their objectives requires that all citizens have access to treatment with stem cells more easily. So he had to seek the cooperation of the country’s various family systems therapy with stem cells. For the benefit of all citizens, regardless. In any country in the world. As a result, the cost of maintaining less than the current “In addition, the stem cells would be useful in the treatment of various diseases ago. The disease is caused by genetics, such as thalassemia can be treated with stem cells, “said the Dr. Anand, who co-founded the Institute for Therapy and Stem Cell (GIOSTAR GLOBAL INSTITUTE OF STEM CELL THERAPY AND RESEARCH). America was paying attention to such institutions in the country. The aim, then, that Thailand is ready thread in many of the medical personnel, and also the right to a Medical Miracle hub of Asia. The last foreigners to be treated in a number of past Dr. Anand has done research on stem cells, together with leading universities in the United States, such as the Medical College of the University of San Diego. Diego, CA, with research on embryonic stem cells and adult life. Or tissues that have been published more than 50 editions of The Dr. Anand has also been internationally recognized as the knowledge.And specialized stem cells And is internationally recognized Dr. Anand had won JISTEC of Science and Technology, Government of Japan. And has presented his research won the award for excellence in the presentation of the “Meeting of Clinical Chemistry and Medicine, Kyoto,

Japan,
Mexico Couture Krajina weak report

The leading Annual Meeting dedicated to the Chemistry Researchers
Register today and join over 400 of your Colleagues

European Chemistry Congress


Dear Dr. Anand S Srivastava,

 

“European Chemistry Congress” on June 16-18, 2016 Rome, a leading forum for Chemists, Drug Analysts, Analytical Chemists, Chemical Engineers, New Chemical Technologies Developers, Nuclear Chemists, Experts in Physical Chemistry, Experts in Drug Discovery and Development, Chemical Industry Professionals, Experts in Organic and Inorganic Chemistry, Medical Biochemistry Experts, Computer Aided Drug Design Experts, Pharma Industry Professionals and Scholars in Chemistry related areas and will encourage Innovation, Educate & Invigorate the attendees.

European Chemistry Congress is the leading annual meeting dedicated to Chemistry research with the theme of Exploring recent advances in chemistry, related fields and applications and that consistently delivers a cutting-edge agenda, 400+ senior delegates, and a sold-out exhibit hall.

Program Coverage
Day 1 June 16, 2016
•Fundamentals of Organic Chemistry
•Inorganic Chemistry
•Analytical Chemistry
•Green Chemistry: Green chemical principles
Day 2 June 17, 2016
•Medical Biochemistry
•Physical Chemistry
•Biological Chemistry
•Environmental Chemistry
Day 3 June 18, 2016
•Nuclear chemistry
•Theoretical Chemistry
•Medicinal Chemistry
•Multi-disciplinary Chemistry

5th European Biosimilars Congress
June 27-29, 2016 Valencia, Spain
“The European perspective of Biologics and Biosimilars”

Meet World leading Biosimilar Industry Leaders from 50+ different Countries
I hope this message finds you well. I’m honored to request you to speak at 5th European Biosimilars Congress happening from June 27-29, 2016 Valencia, Spain and would be so excited if you would join us.
Euro Biosimilars 2016 is a three day event with an audience from leading industries of Biosimilars and follow-on-Biologics sector, contract research organizations, research institutes, patent attorneys, domestic and international regulatory agencies and executive directors of leading biopharmaceutical companies and experts.
Our goal is to bring together bright minds to give talks that are idea-focused, and on a wide range of subjects, to foster learning, inspiration and wonder – and provoke conversations that matter.
UNIQUE FEATURES OF EURO BIOSIMILARS 2016
•Our robust on-line publicity attracts 20000+ users and 60000+ views to our Library of Abstracts which brings worldwide exposure to the researchers and speakers participate in our conferences.
•The Career Guidance Workshops to the Graduates, Doctorates and Post-Doctoral Fellows
•Accepted Abstracts will be published in PubMed, MEDLINE, ProQuest, SCOPUS, SOCOLAR, EBSCO, CAS, Hinari, Index Copernicus, Google Scholar, SCIRUS, DOAJ indexed journals.
•Each abstract will be labeled with a Digital Object Identification Number (DOI) provided by Cross Ref
•Speaker and Abstract pages created in Google on your name would get worldwide acknowledgment to your research profile
CONFERENCE TOPICS
• Current Challenges of Biologics
• Emerging Biosimilars in Therapeutics
• Legal Issues
• Regulatory Approach for Biosimilars
• Biosimilars Innovator Pharmaceutical Products
• Plant Produced Biosimilars
• Bioequivalence Assessment
• Biosimilar Analytical Strategies
• Intellectual Property Rights
• Globalization of Biosimilars
• BCS & IVIVC Based Biowaivers
• Biosimilar Market Analysis
• Biosimilars Pharmacovigilance
• Clinical Studies on Biosimilars
• Entrepreneurs Investment Meet
Benefits:
•Keynote sessions by world’s most eminent researchers and Networking with Experts in the field of Pharma
•Live Streaming of your presentation through our websites and YouTube
•e-Poster for $99
•Outstanding Young Researcher Award and Best Poster Award
•Top Industries Representation
For more details visit our website http://biosimilars-biologics.pharmaceuticalconferences.com/europe/
The Euro Biosimilars 2016 Committee is pleased to announce that they are currently accepting proposals for Symposia and Workshops on the above given topics. All proposals must be submitted to: eurobiosimilars@conferenceseries.com
We believe your voice would be a critical addition to the Euro Biosimilars 2016 stage. Thank you for reading, and we very much look forward to hearing from you.
Best Regards
Badoni Victor
Program Manager- Euro Biosimilars 2016
Email: biosimilars@conferenceseries.com
Contact us
America: 2360 Corporate Circle Suite 400 Henderson
NV 89074-7722 | USA | Tel: +1-650-268-9744
Europe: Heathrow Stockley Park Lakeside House, 1 Furzeground Way, Heathrow, UB11 1BD, UKAsia-Pacific: 6th Floor | North Block | Divyasree Building | Raidurg | Hyderabad 500032 | Tel: 040-33432300

Make An Enquiry

We are here to help you

WordPress Video Lightbox